Back to top
more

Embecta Corp. (EMBC)

(Delayed Data from NSDQ)

$14.25 USD

14.25
134,087

+0.17 (1.21%)

Updated Nov 1, 2024 04:00 PM ET

After-Market: $14.24 -0.01 (-0.07%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value F Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (149 out of 250)

Industry: Medical Services

Better trading starts here.

Zacks News

Embecta Corp. (EMBC) Crossed Above the 200-Day Moving Average: What That Means for Investors

Good things could be on the horizon when a stock surpasses the 200-day simple moving average. How should investors react?

Embecta Corp. (EMBC) Recently Broke Out Above the 50-Day Moving Average

Good things could be on the horizon when a stock surpasses the 50-Day simple moving average. How should investors react?

Company News for May 15, 2023

Companies in The News Are: IAG, SLF, NWSA, EMBC.

Embecta Corp. (EMBC) Dips More Than Broader Markets: What You Should Know

Embecta Corp. (EMBC) closed the most recent trading day at $28.52, moving -1.82% from the previous trading session.

Embecta (EMBC) to Report Q2 Earnings: What's in Store?

Embecta's (EMBC) diabetes care business is expected to have progressed in the fiscal second quarter banking on strong execution of its three strategic pillars.

Embecta Corp. (EMBC) Dips More Than Broader Markets: What You Should Know

Embecta Corp. (EMBC) closed at $27.36 in the latest trading session, marking a -1.12% move from the prior day.

Embecta Corp. (EMBC) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, Embecta Corp. (EMBC) closed at $29.46, marking a +0.58% move from the previous day.

Here's Why You Should Retain Centene (CNC) in Your Portfolio

Strong membership growth, contract wins, accretive acquisitions and streamlining of businesses poise Centene (CNC) well for growth.

Reasons to Retain ShockWave Medical (SWAV) in Your Portfolio

ShockWave Medical (SWAV) continues to benefit from solid R&D endeavors and its commitment to clinical studies.

Here's Why You Should Retain McKesson (MCK) Stock for Now

McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.

New Strong Buy Stocks for April 4th

EMBC, BNPQY, OLLI, CASY and JRVR have been added to the Zacks Rank #1 (Strong Buy) List on April 4, 2023.

Best Momentum Stocks to Buy for March 30th

HQI, EMBC and DTC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 30, 2023.

New Strong Buy Stocks for March 30th

HQI, EMBC, DTC, GSBD and ARLP have been added to the Zacks Rank #1 (Strong Buy) List on March 30, 2023.

Here's Why You Should Retain Elevance (ELV) in Your Portfolio

Strong local presence, improving top line, membership hike and significant new contracts in its government business poise Elevance Health (ELV) well for growth.

Urmimala Biswas headshot

3 Medical Services Stocks to Buy Amid Industry Challenges

The Zacks Medical - Services industry is growing on digital healthcare adoption. EMBC, INNV and OCX are set to gain the most. However, staffing shortages may disrupt the trend.

Reasons to Retain ShockWave Medical (SWAV) in Your Portfolio

ShockWave Medical (SWAV) continues to benefit from solid R&D endeavors and its commitment to clinical studies.

Best Momentum Stocks to Buy for February 24th

PLL, TXT and EMBC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on February 24, 2023.

New Strong Buy Stocks for February 24th

PLL, TXT, EMBC, DE and LCNB have been added to the Zacks Rank #1 (Strong Buy) List on February 24, 2023.

Best Value Stocks to Buy for February 24th

DTEGY, TXT and EMBC made it to the Zacks Rank #1 (Strong Buy) value stocks list on February 24, 2023.

New Strong Buy Stocks for February 21st

EMBC, INSP, REPYY, BZLFY and CVI have been added to the Zacks Rank #1 (Strong Buy) List on February 21, 2023.